Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-15

Clinical Trial Update: A Clinical Trial of Patients With Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial for melanoma sponsored by University of Texas Southwestern Medical Center has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Melanoma | Phase 1 | Status: WITHDRAWN